All Articles

Maintaining a Working Knowledge of Evidence-Based Information
By Sharon S. Gentry, MSN, RN, HON-ONN-CG, AOCN, CBCN
The Editor’s Take
June 2024 Vol 15, No 6
The promotion of screening and early detection guidelines reflect our commitment to the Oncology Navigation Standards of Professional Practice.
Read More
Managing Lymphedema Through Movement
By Jenny Spencer, RN, BSN, OCN, CPT, CETI CES
Side-Effects Management
June 2024 Vol 15, No 6
Muscular contraction aids in lymph movement, making exercise a natural option for decreasing risk of and treating cancer-related lymphedema.
Read More
Enhancing Patient Care Through Industry Collaboration
Highlights From AONN+, Navigation
June 2024 Vol 15, No 6
Oncology nurse educators and reimbursement field managers representing pharma are an invaluable resource for navigators.
Read More
The Lonely City
The Gallery
June 2024 Vol 15, No 6
Oncology social worker, AONN+ member, osteosarcoma survivor, and artist Deysi Barzallo shares her beautiful works of art as the JONS Artist in Residency.
Read More
Highlights of Expert Commentary of OFS
Best Practices in Breast Cancer Therapy | OFS
Highlights of Expert Commentary of OFS
Best Practices
Video Library
In this final video, Polly Niravath, MD, Abbey Kaler, APRN, FNP-C, CMSRN, and Emily Beard, RN, BSN, OCN, CBCN, CG, discuss the clinical features of premenopausal women with breast cancer who may be suitable for treatment with ovarian function suppression (OFS) therapy, effective use of OFS therapy, and relevant navigation strategies used to address the potential challenges associated with OFS treatment.
Read More
Estrogen Receptor–Positive (ER+), Premenopausal, Metastatic Breast Cancer Treatment Journey: Consideration of Ovarian Function Suppression (OFS) Drug Therapy
Estrogen Receptor–Positive (ER+), Premenopausal, Metastatic Breast Cancer Treatment Journey: Consideration of Ovarian Function Suppression (OFS) Drug Therapy
Resources
The Academy of Oncology Nurse & Patient Navigators, with support from TerSera Therapeutics, is delighted to offer you a resource to assist with educating your premenopausal patients with estrogen receptor-positive metastatic breast cancer and their caregivers as they navigate through the treatment journey, including managing the effects of ovarian function suppression drug therapy.
Read More
Managing Clinical and Psychosocial Impacts of OFS
Best Practices in Breast Cancer Therapy | OFS
Managing Clinical and Psychosocial Impacts of OFS
Best Practices
Video Library
Hear expert commentary on ovarian function suppression (OFS) side effect management, including strategies used to address psychosocial challenges affecting premenopausal breast cancer patients undergoing OFS.
Read More
Setting Patient Expectations of OFS Treatment
Best Practices in Breast Cancer Therapy | OFS
Setting Patient Expectations of OFS Treatment
Best Practices
Video Library
Listen as a nurse navigator discusses ovarian function suppression (OFS) and the subsequent impact of OFS on premenopausal women with breast cancer.
Read More

Page 21 of 281

Journal of Oncology Navigation & Survivorship

Contact Us | Editorial Board

Amplity

© Amplity, Inc. All rights reserved.

Connect with Us

 
 
JONS

Subscribe Today!

To sign up for our print publication or e-newsletter, please enter your contact information below.

I'd like to receive:

  • First Name *
    Last Name *
     
    Profession or Role
    Primary Specialty or Disease State
    Country

Back to Top

Amplity © Amplity, Inc. All rights reserved.